Medical Device Globalization Accelerates as Vision Medical Expands Across Asia-Pacific, Latin America and Other Key Emerging Markets | Unity Ventures Portfolio
China's MedTech Manufacturing Takes the Global Stage
Unity Ventures portfolio company Lingmou Medical has scored a major breakthrough in overseas markets. Since launching its internationalization strategy last July, its overseas business has delivered standout results — with more than 70 units sold through international channels alone, ranking first among emerging Chinese brands in digestive endoscopy for overseas deliveries. Its products have already entered over 25 core markets globally across Asia-Pacific, the Middle East, and Latin America, demonstrating formidable expansion momentum abroad.
Lingmou Medical has also distinguished itself at home. As a rising industry brand, it secured placements at multiple large tertiary Grade A hospitals led by national and provincial deputy directors in its first commercial year — a strong signal of recognition from top-tier medical institutions for its product quality and technical capabilities.
As a key piece of Unity Ventures' global investment strategy in the medical devices sector, Lingmou Medical focuses on R&D and commercialization of full-scenario solutions for flexible endoscopy. Its founding team all hail from listed industry leaders, with hands-on experience shepherding domestic flexible endoscopes from zero to scale.
The company brings deep expertise in optical systems, pioneering a "full-scenario imaging" concept with bleeding-point detection by integrating multi-spectral light sources. The system combines four imaging modes — HLI (true-color white light imaging), SVI (narrow-band shallow imaging), TCI (color separation imaging), and DHI (red-light deep imaging), the last being exclusive among domestic manufacturers — to target the submucosal blind spots that conventional equipment misses, achieving layer-specific imaging of mucosal tissue and enabling full-scenario applications from screening and diagnosis to treatment.
Going forward, Unity Ventures will continue to embrace a global investment perspective and deepen its presence in medical devices and broader biomedicine, betting on the global potential of "Intelligent Manufacturing in China" to support domestic medtech companies in going international and bringing innovative technologies to patients and clinicians worldwide.
